Abstract:Objective: To investigate the association between the imaging biomarker (volumetric perivascular characterization index [VPCI]) which indicates the aortic wall inflammation by mapping the spatial changes of perivascular fat attenuation on computed tomography angiography (CTA) and the reintervention risk for abdominal aortic aneurysm (AAA) patients after endovascular aortic repair (EVAR). Methods: This case-control study included AAA patients undergoing EVAR from a single center (n=260). Cases were AAA patients undergoing reintervention after EVAR and a 1:1 frequency-matched control group of AAA patients post-EVAR with a shrunken or ≥3-year stable sac and free of reintervention signs during the follow-up. The predictive variable (VPCI trajectory) was converted to binary variables according to the changing trend of VPCI with follow-up time. As a quasi-complete separation data pattern, least absolute shrinkage and selection operator (lasso) regression was used to screen and prove the VPCI trajectory as the best predictor, and the performance was evaluated by calculating the accuracy, sensitivity, and specificity. Results: Between 2010 and 2021, 15 AAA patients after EVAR with type I/III endoleak, aneurysm rupture, or impending rupture were included. Compared with the 1:1 frequency-matched controls with a shrunken or ≥3-year stable sac and free of reintervention signs during the follow-up, VPCI trajectories of the case group were all upward trends, whereas the controls showed 86.7% downward trends (p<0.001). The best predictive model of lasso regressions included 4 variables, and VPCI trajectory was the most outstanding, followed by the proximal landing zone, the distal landing zone, and the infrarenal β angle. The accuracy, sensitivity, and specificity of predicting the risk of reintervention were as follows, respectively: 93.3%, 100%, and 86.7%. Conclusions: The wall inflammation detected by imaging perivascular adipose tissue based on the CTAs was strongly associated with the reintervention risk for AAA patients after EVAR, which might hold major promise as a new imaging biomarker for the mechanism and treatment study of human AAAs before and after EVAR. Clinical impact: The study introduces a novel imaging biomarker which indicates the aortic wall inflammation by mapping spatial changes of perivascular fat attenuation on CTA. This biomarker demonstrates a strong association with the reintervention risk in AAA patients after EVAR. Incorporation of VPCI into clinical practice has the potential to enhance the traditional surveillance methods (CT/CTAs) by providing clinicians with a non-invasive method to assess aortic wall inflammation and predict the risk of reintervention. Additionally, this study might offer a valuable tool for mechanism and treatment research in humans with AAAs both pre- and post-EVAR, ultimately improving patient outcomes and refining therapeutic strategies.

Evaluation of Circulating Endothelial Progenitor Cells in Abdominal Aortic Aneurysms after Endovascular Aneurysm Repair

The correlation between the number of endothelial progenitor cells in the peripheral blood and abdominal aortic aneurysm

Enhancement of Viability of Fat Grafts in Nude Mice by Endothelial Progenitor Cells

Mobilization of Circulating Endothelial Progenitor Cells after Endovascular Therapy for Ruptured Cerebral Aneurysms.

Endothelial progenitor cells contribute to neointima formation in rabbit elastase-induced aneurysm after flow diverter treatment.

Bone Marrow-Derived Endothelial Progenitor Cells Are Involved in Aneurysm Repair in Rabbits

CXCL12 Regulates Bone Marrow–derived Endothelial Progenitor Cells to Promote Aortic Aneurysm Recovery

Circulating CD34+VEGFR-2+ Endothelial Progenitor Cells Correlate with Revascularization-Mediated Long-Term Improvement of Cardiac Function in Patients with Coronary Chronic Total Occlusions

Changes in the Number of Endothelial Progenitor Cells from Peripheral Blood and Significance in Mouse Abdominal Aortic Allografts

A Preliminary Study of the Therapeutic Role of Human Early Fetal Aorta-derived Endothelial Progenitor Cells in Inhibiting Carotid Artery Neointimal Hyperplasia.

Decreased Levels and Function of Circulating Endothelial Progenitor Cells in Unruptured Intracranial Saccular Aneurysm Patients

Early Intervention Effects of Open Repair and Endovascular Aortic Repair on Patients Suffering from 40-54 Mm Abdominal Aortic Aneurysms: Single Center Experience.

Endothelial progenitor cells restore renal function in chronic experimental renovascular disease

Endothelial Progenitor Cells in Coronary Atherosclerosis and Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis

Administration of in vitro expanded bone marrow-derived endothelial progenitor cells (EPCs) contribute to the development of neointimal thickenings in mouse aortic allografts

Effects of EDC-PEI Heparinization on Allogeneic Vascular Antigens and Inflammation Levels Via a Rat Abdominal Aorta Transplantation Model

Endothelial Progenitor Cells Improve Functional Recovery in Focal Cerebral Ischemia of Rat by Promoting Angiogenesis Via VEGF.

Changes and Function of Circulating Endothelial Progenitor Cells in Patients with Cerebral Aneurysm

Endovascular treatment of thoracoabdominal aortic aneurysms using physician modified Ankura endo-grafts

NEAT1 promotes the repair of abdominal aortic aneurysms of endothelial progenitor cells via regulating miR-204-5p/Ang-1

Association Between Aneurysm Wall Inflammation Detected by Imaging Perivascular Fat and Secondary Intervention Risk for Abdominal Aortic Aneurysm Patients After Endovascular Repair